Cargando…
Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases
[Image: see text] DYRK kinases are involved in alternative pre-mRNA splicing as well as in neuropathological states such as Alzheimer's disease and Down syndrome. In this study, we present the design, synthesis, and biological evaluation of indirubins as DYRK inhibitors with enhanced selectivit...
Autores principales: | Myrianthopoulos, Vassilios, Kritsanida, Marina, Gaboriaud-Kolar, Nicolas, Magiatis, Prokopios, Ferandin, Yoan, Durieu, Emilie, Lozach, Olivier, Cappel, Daniel, Soundararajan, Meera, Filippakopoulos, Panagis, Sherman, Woody, Knapp, Stefan, Meijer, Laurent, Mikros, Emmanuel, Skaltsounis, Alexios-Leandros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2012
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545483/ https://www.ncbi.nlm.nih.gov/pubmed/23336033 http://dx.doi.org/10.1021/ml300207a |
Ejemplares similares
-
Impact of binding site waters on inhibitor design: contemplating a novel inverse binding mode of indirubin derivatives in DYRK kinases
por: Cappel, Daniel, et al.
Publicado: (2014) -
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3
por: Efstathiou, Antonia, et al.
Publicado: (2014) -
The Indirubin Derivative 6-Bromoindirubin-3′-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects
por: Tsakiri, Eleni N., et al.
Publicado: (2017) -
Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents
por: Efstathiou, Antonia, et al.
Publicado: (2018) -
6-bromo-indirubin-3′-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts
por: Sklirou, Aimilia D., et al.
Publicado: (2017)